Teprotumumab N01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Teprotumumab N01, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease. [NA]